Niklander S, Marín C, Martínez R, Esguep A. Morphea “en coup de sabre”: An unusual oral presentation. J Clin Exp Dent. 2017;9(2):e315-8.

doi:10.4317/jced.53151

http://dx.doi.org/doi:10.4317/jced.53151

References

1. Van der Veken D, De Haes P, Hauben E, Teughels W, Lambrechts P. A rare cause of gingival recession: morphea with intra-oral involvement. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:257-64.
https://doi.org/10.1016/j.oooo.2015.02.002
PMid:25864825

2. Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2011;64:217-28.
https://doi.org/10.1016/j.jaad.2010.05.045
PMid:21238823

3. Bielsa Marsol B. Update on the classification and treatment of localized scleroderma. Actas Dermosifiliogr. 2013;104:654-66.

PMid: 23948159

4. Pace C, Ward SE, Pace A. A rare case of frontal linear scleroderma (en coup de sabre) with intra-oral and dental involvement. Br Dent J. 2010;208:249-50.
https://doi.org/10.1038/sj.bdj.2010.252
PMid:20339416

5. Tang MM, Bornstein MM, Irla N, Beltraminelli H, Lombardi T, Borradori L. Oral mucosal morphea: a new variant. Dermatology. 2012;224:215-20.
https://doi.org/10.1159/000337554
PMid:22538799

6. Taniguchi T, Asano Y, Tamaki Z, Akamata K, Aozasa N, Noda S, et al. Histological features of localized scleroderma 'en coup de sabre': a study of 16 cases. J Eur Acad Dermatol Venereol. 2014;28:1805-10.
https://doi.org/10.1111/jdv.12280
PMid:24118540

7. Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol. 2008;59:385-96.
https://doi.org/10.1016/j.jaad.2008.05.005
PMid:18571769

8. Dharamsi JW1, Victor S, Aguwa N, Ahn C, Arnett F, Mayes MD, Jacobe H. Morphea in Adults and Children Cohort III: Nested case-control study-the clinical significance of autoantibodies in morphea. JAMA Dermatol. 2013;149:1159-65.
https://doi.org/10.1001/jamadermatol.2013.4207
PMid:23925398 PMCid:PMC4153681

9. Liu XS, Gao Y, Zheng LW, Hua H. New alternative therapy for orofacial localized scleroderma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:15-9.
https://doi.org/10.1016/j.tripleo.2010.04.004
PMid:20634110

10. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology. 2006;45:614-20.
https://doi.org/10.1093/rheumatology/kei251
PMid:16368732

11. Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM. Clinical features of childhood localized scleroderma in an incidence cohort. Rheumatology. 2011;50:1865-8.
https://doi.org/10.1093/rheumatology/ker142
PMid:21729934

12. Torok K, Arkachaisri T. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single center study. J Rheumatol. 2012;39:286-94.
https://doi.org/10.3899/jrheum.110210
PMid:22247357 PMCid:PMC3744892

13. Koch S, Cerci F, Jorizzo J, Krochuk D. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients. Journal of Dermatological Treatment. 2013;24:435-8.
https://doi.org/10.3109/09546634.2013.806769
PMid:23758214

14. Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, et al. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol. 2012;67:1151-6.
https://doi.org/10.1016/j.jaad.2012.03.036
PMid:22657157